triazoles has been researched along with Dysthymic Disorder in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnow, BA; Blalock, JA; Keitner, GI; Klein, DN; Maddux, RE; Manber, R; Markowitz, JC; Riso, LP; Rothbaum, BO; Thase, ME | 1 |
Crits-Christoph, P; Klein, DN; Manber, R; Stulz, N; Thase, ME | 1 |
Bird, D; Dursun, SM; Ronson, KE | 1 |
Arnow, B; Blalock, JA; Borian, FE; Castonguay, LG; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Miller, IW; Riso, LP; Rothbaum, B; Santiago, NJ; Schwartz, JE; Thase, ME; Vivian, D; Vocisano, C | 1 |
Arnow, BA; Blalock, JA; Blasey, C; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Riso, LP; Rothbaum, BO; Rush, AJ; Thase, ME; Vivian, D | 1 |
al-Dubai, Z; Beraus, W; Conca, A; König, P | 1 |
Dunner, DL | 1 |
1 review(s) available for triazoles and Dysthymic Disorder
Article | Year |
---|---|
Acute and maintenance treatment of chronic depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Dysthymic Disorder; Humans; Multicenter Studies as Topic; Piperazines; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Triazoles | 2001 |
4 trial(s) available for triazoles and Dysthymic Disorder
Article | Year |
---|---|
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Culture; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Personality Disorders; Personality Inventory; Piperazines; Problem Solving; Recurrence; Triazoles | 2009 |
Differential effects of treatments for chronic depression: a latent growth model reanalysis.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Models, Psychological; Personality Inventory; Piperazines; Psychometrics; Secondary Prevention; Triazoles | 2010 |
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Piperazines; Professional-Patient Relations; Recurrence; Triazoles | 2003 |
Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Defense Mechanisms; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Internal-External Control; Male; Middle Aged; Motivation; Personality Inventory; Piperazines; Psychometrics; Treatment Outcome; Triazoles | 2003 |
2 other study(ies) available for triazoles and Dysthymic Disorder
Article | Year |
---|---|
Nefazodone treatment of dysthymic disorder an open, long-term, prospective pilot study.
Topics: Adult; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Triazoles | 2002 |
Combining nefazodone and midazolam during ECT.
Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Drug Interactions; Dysthymic Disorder; Electroconvulsive Therapy; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Neuromuscular Depolarizing Agents; Piperazines; Succinylcholine; Thiopental; Treatment Outcome; Triazoles | 1999 |